EP1819722A4 - MODULATION OF OVULATION - Google Patents

MODULATION OF OVULATION

Info

Publication number: EP1819722A4
Authority: EP; European Patent Office
Prior art keywords: ovulation; modulation
Prior art date: 2004-12-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP05823157A

Other languages

German (de)

French (fr)

Other versions

EP1819722A1 (en

Inventor

Jennifer Lee Juengel

Kenneth Pattrick Mcnatty

Lloyd Gary Moore

Robert Syndecombe Bower

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

AgResearch Ltd

Original Assignee

AgResearch Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-02

Filing date

2005-12-02

Publication date

2009-09-09

2004-12-02 Priority claimed from NZ53694304A external-priority patent/NZ536943A/en

2005-12-02 Application filed by AgResearch Ltd filed Critical AgResearch Ltd

2007-08-22 Publication of EP1819722A1 publication Critical patent/EP1819722A1/en

2009-09-09 Publication of EP1819722A4 publication Critical patent/EP1819722A4/en

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Reproductive Health (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pregnancy & Childbirth (AREA)
Zoology (AREA)
Toxicology (AREA)
Gynecology & Obstetrics (AREA)
Gastroenterology & Hepatology (AREA)
Virology (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP05823157A 2004-12-02 2005-12-02 MODULATION OF OVULATION Withdrawn EP1819722A4 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
NZ53694304A NZ536943A (en)	2004-12-02	2004-12-02	Modulation of ovulation
NZ53903905		2005-03-24
NZ54117005		2005-07-08
PCT/NZ2005/000313 WO2006059913A1 (en)	2004-12-02	2005-12-02	Modulation of ovulation

Publications (2)

Publication Number	Publication Date
EP1819722A1 EP1819722A1 (en)	2007-08-22
EP1819722A4 true EP1819722A4 (en)	2009-09-09

Family

ID=36565307

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP05823157A Withdrawn EP1819722A4 (en)	2004-12-02	2005-12-02	MODULATION OF OVULATION

Country Status (6)

Country	Link
EP (1)	EP1819722A4 (en)
JP (1)	JP2008521891A (en)
AU (1)	AU2005310356A1 (en)
BR (1)	BRPI0518809A2 (en)
CA (1)	CA2589898A1 (en)
WO (1)	WO2006059913A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006130022A1 (en) *	2005-05-30	2006-12-07	Agresearch Limited	Modulation of ovulation by agonists and antagonists of bmprii
US8530235B2 (en)	2005-07-18	2013-09-10	Adelaide Research & Innovation Pty Ltd.	Medium that supports culture of an oocyte and modulation of granulosa cell apoptosis
BRPI0706173C1 (en) *	2007-11-23	2011-02-22	Brasil Pesquisa Agropec	method for mass identification of animals with increased prolificacy
US11702457B2 (en)	2018-05-09	2023-07-18	Monash University	Agent and method for enhancing fertility

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999017797A1 (en) *	1997-10-06	1999-04-15	The Johns Hopkins University School Of Medicine	Use of growth differenciation factor-9 (gdf-9) as a contraceptive
US6191261B1 (en) *	1993-01-12	2001-02-20	The Johns Hopkins University School Of Medicine	Growth differentiation factor-9 antibodies and methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ519330A (en) *	2002-05-30	2004-12-24	George Henry Davis	New sequences for altering mammalian ovarian function and ovulation rate

2005
- 2005-12-02 JP JP2007544297A patent/JP2008521891A/en active Pending
- 2005-12-02 BR BRPI0518809-1A patent/BRPI0518809A2/en not_active Application Discontinuation
- 2005-12-02 CA CA002589898A patent/CA2589898A1/en not_active Abandoned
- 2005-12-02 EP EP05823157A patent/EP1819722A4/en not_active Withdrawn
- 2005-12-02 AU AU2005310356A patent/AU2005310356A1/en not_active Abandoned
- 2005-12-02 WO PCT/NZ2005/000313 patent/WO2006059913A1/en active Application Filing

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6191261B1 (en) *	1993-01-12	2001-02-20	The Johns Hopkins University School Of Medicine	Growth differentiation factor-9 antibodies and methods
WO1999017797A1 (en) *	1997-10-06	1999-04-15	The Johns Hopkins University School Of Medicine	Use of growth differenciation factor-9 (gdf-9) as a contraceptive

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JUENGEL J L ET AL: "Growth differentiation factor 9 and bone morphogenetic protein 15 are essential for ovarian follicular development in sheep", BIOLOGY OF REPRODUCTION, SOCIETY FOR THE STUDY OF REPRODUCTION, CHAMPAIGN, IL, US, vol. 67, 4 October 2002 (2002-10-04), pages 1777 - 1789, XP002999768, ISSN: 0006-3363 *
MCNATTY KP ET AL: "The Effects of Immunizing Sheep with Different BMP15 or GDF9 Peptide Sequences on Ovarian Follicular Activity and Ovulation Rate", BIOLOGY OF REPRODUCTION, vol. 76, 8 November 2006 (2006-11-08), pages 552 - 560, XP002538978, DOI: 10.1095/biolreprod.106.054361 *
See also references of WO2006059913A1 *

Also Published As

Publication number	Publication date
JP2008521891A (en)	2008-06-26
AU2005310356A1 (en)	2006-06-08
WO2006059913A9 (en)	2008-05-22
BRPI0518809A2 (en)	2008-12-09
CA2589898A1 (en)	2006-06-08
EP1819722A1 (en)	2007-08-22
WO2006059913A1 (en)	2006-06-08

Publication	Publication Date	Title
NO2017058I1 (en)	2017-11-10	HPV 58 L1 protein
NO2017012I1 (en)	2017-04-05	HPV 45 L1 protein
EP1633307A4 (en)	2009-06-24	MODULATION OF SURVIVIN EXPRESSION
DE60316652D1 (en)	2007-11-15	endoscope
DE60336213D1 (en)	2011-04-14	SURGICAL CLAWER
DK1575597T3 (en)	2009-03-16	Use of rimexolone for the treatment of eye dryness
EP1746141A4 (en)	2010-04-07	COMPOSITION FOR THICKENING
DK1646311T3 (en)	2009-02-23	Endoscopic fastener
EP1827473A4 (en)	2009-08-19	MODULATORS OF TOXICITY OF ALPHA-SYNUCLEIN
FR2847154B3 (en)	2004-10-15	REMOVABLE TOOTH-CUT ARCHITECTURE
EP1685147A4 (en)	2008-04-09	MODULATION OF SGLT2 EXPRESSION
DE602004002056D1 (en)	2006-10-05	Fixation d'un coussin gonflable
EP1924288A4 (en)	2009-11-25	CELLULAR LINES WHO ARE FULLY HUMAN FUSION PARTNERS OF HYBRIDOMES
DE60326190D1 (en)	2009-04-02	of the body
FR2875398B1 (en)	2007-07-06	JOINT IMPLANT OF INTERPOSITION
EP1714656A4 (en)	2012-10-31	PREPARATION OF ED-71
FR2845267B1 (en)	2004-12-31	SKIN DIAGNOSTIC KIT FOR ATOPIA
DE10309491B8 (en)	2005-09-08	Surgical clip
EP1819722A4 (en)	2009-09-09	MODULATION OF OVULATION
EP1809646A4 (en)	2009-05-06	GLYCINE RIBOSWITCHES, METHODS OF USE, AND COMPOSITIONS USING THE RIBOSWITCHES
EP1646401A4 (en)	2007-07-18	SPECIFIC HUMAN ANTIBODIES
EP1756276A4 (en)	2008-10-29	CRUSTACE EXPRESSION VECTOR
FR2864540B1 (en)	2010-10-22	NOVEL OLIGONUCLEOTIDES AND USE OF OLIGONUCLEOTIDES MODULATING THE EXPRESSION OF TYROSINASE AND TYROSINASE-RELATED-PROTEIN 1 AS DEPIGMENTING AGENTS
ITSV20040008A1 (en)	2004-05-18	DOCTOR "G"
FR2852042B1 (en)	2006-05-19	ARETIER PIECE

Legal Events

Date	Code	Title	Description
2007-07-20	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2007-08-22	17P	Request for examination filed	Effective date: 20070626
2007-08-22	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
2008-03-12	DAX	Request for extension of the european patent (deleted)
2009-09-02	RIC1	Information provided on ipc code assigned before grant	Ipc: A61P 15/08 20060101ALI20090730BHEP Ipc: A61K 39/395 20060101ALI20090730BHEP Ipc: C07K 14/495 20060101ALI20090730BHEP Ipc: C07K 14/51 20060101ALI20090730BHEP Ipc: C07K 16/22 20060101ALI20090730BHEP Ipc: A61K 38/10 20060101ALI20090730BHEP Ipc: C07K 7/08 20060101AFI20060619BHEP Ipc: C07K 14/475 20060101ALI20090730BHEP
2009-09-09	A4	Supplementary search report drawn up and despatched	Effective date: 20090807
2010-04-09	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2010-05-12	18D	Application deemed to be withdrawn	Effective date: 20091105